Pharma Co. Sued For $12M For Underpaying Board Chair
Altum Pharmaceuticals and its cannabis-focused parent company were hit with a $12 million suit Thursday, accusing the companies and several executives of self-dealing and stock dilution and underpaying the executive chairman...To view the full article, register now.
Already a subscriber? Click here to view full article